Literature DB >> 16277718

Urinary bladder partial carbon dioxide tension during hemorrhagic shock and reperfusion: an observational study.

Arnaldo Dubin1, Mario O Pozo, Vanina S Kanoore Edul, Gastón Murias, Héctor S Canales, Marcelo Barán, Bernardo Maskin, Gonzalo Ferrara, Mercedes Laporte, Elisa Estenssoro.   

Abstract

INTRODUCTION: Continuous monitoring of bladder partial carbon dioxide tension (PCO2) using fibreoptic sensor technology may represent a useful means by which tissue perfusion may be monitored. In addition, its changes might parallel tonometric gut PCO2. Our hypothesis was that bladder PCO2, measured using saline tonometry, will be similar to ileal PCO2 during ischaemia and reperfusion.
METHOD: Six anaesthetized and mechanically ventilated sheep were bled to a mean arterial blood pressure of 40 mmHg for 30 min (ischaemia). Then, blood was reinfused and measurements were repeated at 30 and 60 min (reperfusion). We measured systemic and gut oxygen delivery and consumption, lactate and various PCO2 gradients (urinary bladder-arterial, ileal-arterial, mixed venous-arterial and mesenteric venous-arterial). Both bladder and ileal PCO2 were measured using saline tonometry.
RESULTS: After bleeding systemic and intestinal oxygen supply dependency and lactic acidosis ensued, along with elevations in PCO2 gradients when compared with baseline values (all values in mmHg; bladder DeltaPCO2 3 +/- 3 versus 12 +/- 5, ileal DeltaPCO2 9 +/- 5 versus 29 +/- 16, mixed venous-arterial PCO2 5 +/- 1 versus 13 +/- 4, and mesenteric venous-arterial PCO2 4 +/- 2 versus 14 +/- 4; P < 0.05 versus basal for all). After blood reinfusion, PCO2 gradients returned to basal values except for bladder DeltaPCO2, which remained at ischaemic levels (13 +/- 7 mmHg).
CONCLUSION: Tissue and venous hypercapnia are ubiquitous events during low flow states. Tonometric bladder PCO2 might be a useful indicator of tissue hypoperfusion. In addition, the observed persistence of bladder hypercapnia after blood reinfusion may identify a territory that is more susceptible to reperfusion injury. The greatest increase in PCO2 gradients occurred in gut mucosa. Moreover, the fact that ileal DeltaPCO2 was greater than the mesenteric venous-arterial PCO2 suggests that tonometrically measured PCO2 reflects mucosal rather than transmural PCO2. Ileal DeltaPCO2 appears to be the more sensitive marker of ischaemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16277718      PMCID: PMC1297623          DOI: 10.1186/cc3797

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


Introduction

Monitoring the adequacy of tissue oxygenation in critically ill patients is a challenging task [1]. Despite extensive research, tissue capnometry remains the only clinically relevant approach to monitoring regional perfusion and oxygenation. Elevation in tissue partial carbon dioxide tension (PCO2) might represent a better surrogate of hypoperfusion than other systemic and regional parameters [2,3]. During the past 20 years a large body of clinical evidence was developed supporting the usefulness of gastrointestinal PCO2 tonometry for the monitoring of tissue perfusion [4]. Gastric tonometry can readily be performed in the critically ill and gives significant information on outcomes [5,6]. It may also be a helpful guide in therapeutic decision making [7]. Nevertheless, technical difficulties and frequent artefacts have dampened the initial enthusiasm [8]. In an attempt to overcome the limitations of gastric tonometry, sublingual capnometry was then developed [9]. Despite initial interest and potential advantages, this technique has neither been completely validated nor widely used [10]. More recently, tissue perfusion has been assessed with continuous monitoring of bladder PCO2 using fibreoptic sensor technology [11,12], yielding interesting findings in experimental models of ischaemia/reperfusion. Although the equipment required may be expensive, bladder PCO2 can readily be measured via a urinary catheter incorporating a silicone balloon. Our goal in the present study was to compare bladder PCO2 measured using saline tonometry versus other tissue and venous PCO2 values. Our hypothesis was that bladder PCO2 will track ileal PCO2 during ischaemia and reperfusion.

Materials and methods

Surgical preparation

Six sheep were anaesthetized with 30 mg/kg sodium pentobarbital, intubated and mechanically ventilated (Harvard Apparatus Dual Phase Control Respirator Pump Ventilator; South Natick, MA, USA) with a tidal volume of 15 ml/kg, a fractional inspired oxygen of 0.21, and positive end-expiratory pressure adjusted to maintain arterial oxygen saturation above 90%. The respiratory rate was set to keep the end-tidal PCO2 at 35 mmHg. Neuromuscular blockade was applied with intravenous pancuronium bromide (0.06 mg/kg). Additional pentobarbital boluses (1 mg/kg per hour) were administered. Catheters were advanced through the left femoral vein to administer fluids and drugs, and through left femoral artery to measure blood pressure and obtain blood gases. A pulmonary artery catheter was inserted through the right external jugular vein (Flow-directed thermodilution fibreoptic pulmonary artery catheter; Abbott Critical Care Systems, Mountain View, CA, USA). An orogastric tube was inserted to allow drainage of gastric contents. Then, a midline laparotomy and splenectomy were performed. An electromagnetic flow probe was placed around the superior mesenteric artery to measure intestinal blood flow. A catheter was placed in the mesenteric vein through a small vein proximal to the gut to draw blood gases. Tonometers (TRIP Sigmoid Catheter; Tonometrics, Inc., Worcester, MA, USA) were inserted through small ileotomy and cystostomy to measure ileal and urinary bladder intramucosal PCO2. A second catheter was placed through the same cystostomy to drain urine. Finally, after careful haemostasis, the abdominal wall incision was closed.

Measurements and derived calculations

Arterial, systemic, pulmonary and central venous pressures were measured using corresponding transducers (Statham P23 AA; Statham, Hato Rey, Puerto Rico). Cardiac output was measured by thermodilution with 5 ml saline solution at 0°C (HP OmniCare Model 24 A 10; Hewlett Packard, Andover, MA, USA). An average of three measurements taken randomly during the respiratory cycle was considered and was referenced to body weight to yield the cardiac output (Q). Intestinal blood flow was measured with the electromagnetic method (Spectramed Blood Flowmeter model SP 2202 B; Spectramed Inc., Oxnard, CA, USA) with in vitro calibrated transducers of 5–7 mm diameter (Blood Flowmeter Transducer; Spectramed Inc.). Occlusive zero was controlled before and after each experiment. Non-occlusive zero was corrected before each measurement. Superior mesenteric blood flow was referenced to gut weight (Qintestinal). Arterial, mixed venous and mesenteric venous partial oxygen tension (PO2), PCO2 and pH were measured using a blood gas analyzer (ABL 5; Radiometer, Copenhagen, Denmark), and haemoglobin and oxygen saturation were measured using a co-oximeter calibrated for sheep blood (OSM 3; Radiometer). Arterial oxygen content (CaO2), mixed venous oxygen content (CvO2) and mesenteric venous oxygen content (CvmO2) were calculated as follows: haemoglobin × 1.34 × oxygen saturation + PO2 × 0.0031. Systemic and intestinal oxygen delivery (DO2) and oxygen consumption (VO2) were calculated as follows: systemic DO2 = Q × CaO2; systemic VO2 = Q × (CaO2 - CvO2); intestinal DO2 = Qintestinal × CaO2; and intestinal VO2 = Qintestinal × (CaO2 - CvmO2). Arterial lactate concentration was measured using an automatic analyzer (Hitachi 912; Boehringer Mannheim Corporation, Indianapolis, IN, USA). Bladder and ileal intramucosal PCO2 were measured using a tonometer filled with 2.5 ml saline solution. Of the solution, 1.0 ml was discarded after an equilibration period of 30 min, and PCO2 was measured in the remaining 1.5 ml. These values were corrected for the equilibration period and were used to calculate intramucosal-arterial gradients (bladder and ileal ΔPCO2). Mixed venous–arterial PCO2 (Pv–aCO2) and mesenteric venous–arterial PCO2 differences (Pvm–aCO2) were also calculated.

Experimental procedure

Basal measurements were taken after a stabilization period longer than 30 min. Then, sheep were bled to a mean arterial blood pressure of 40 mmHg for 30 min (ischaemia). This degree of arterial hypotension was maintained by extracting or returning blood, as necessary. Collected blood was heparinized (5,000 U/l) and stored in a warmed water bath (37.5°C). Then, blood was reinfused and measurements were repeated at 30 and 60 min (reperfusion). At the end of the experiment the animals were killed with an additional dose of pentobarbital and a KCl bolus. A catheter was inserted into the superior mesenteric artery and Indian ink was instilled. Dyed intestinal segments were dissected, washed and weighed to calculate gut indices. The local Animal Care Committee approved the study. Care of animals was in accordance with US National Institute of Health guidelines.

Statistical analysis

Data were assessed for normality and expressed as mean ± standard deviation. Differences were analyzed using repeated measures analysis of variance and Dunnett's multiple comparisons test to compare each time point with baseline. One-time comparisons between different PCO2 gradients were tested using one-way analysis of variance and Newman–Keuls multiple comparisons test.

Results

Haemodynamic and oxygen transport effects

Mean arterial pressure decreased during bleeding, as did Q, Qintestinal and systemic and intestinal DO2 and VO2. These variables returned to basal values after reinfusion of blood, with the exception of mean arterial pressure and systemic VO2, which remained higher than basal values (Table 1).
Table 1

Haemodynamic and oxygen transport parameters at basal conditions, during ischaemia, and after 30 and 60 min of reperfusion

Reperfusion

ParameterBasalIschemia30 min60 min
Mean arterial blood pressure (mmHg)87 ± 1438 ± 4105 ± 10*104 ± 10*
Cardiac output (ml/min per kg)138 ± 1070 ± 17*136 ± 17137 ± 16
Intestinal blood flow (ml/min per kg)787 ± 181272 ± 100*890 ± 278756 ± 134
Systemic oxygen transport (ml/min per kg)19.5 ± 2.77.8 ± 1.9*18.8 ± 2.819.3 ± 3.2
Systemic oxygen consumption (ml/min per kg)6.8 ± 1.05.7 ± 1.5*7.4 ± 1.2*7.2 ± 0.9*
Systemic oxygen extraction ratio0.35 ± 0.060.72 ± 0.08*0.40 ± 0.09*0.39 ± 0.09
Intestinal oxygen transport (ml/min per kg)112.5 ± 35.231.1 ± 14.0*126.1 ± 51.1107.8 ± 28.7
Intestinal oxygen consumption (ml/min per kg)30.3 ± 4.619.3 ± 7.1*31.3 ± 6.931.5 ± 6.6
Intestinal oxygen extraction ratio0.29 ± 0.090.65 ± 0.12*0.28 ± 0.110.31 ± 0.10

*P < 0.05 versus basal.

Metabolic effects

Metabolic acidosis and hyperlactataemia developed during ischaemia, and persisted after reinfusion (Table 2).
Table 2

Arterial, mixed venous and mesenteric venous blood gases, and arterial lactate at basal conditions, during ischemia and after 30 and 60 minutes of reperfusion

Reperfusion

ParameterBasalIschaemia30 min60 min
Arterial pH7.37 ± 0.037.36 ± 0.057.33 ± 0.05*7.36 ± 0.04
Arterial PCO2 (mmHg)38 ± 435 ± 5*36 ± 436 ± 5
Arterial PO2 (mmHg)77 ± 980 ± 1575 ± 1078 ± 8
Arterial HCO3- (mmol/l)22 ± 319 ± 2*19 ± 2*20 ± 2*
Arterial base excess (mmol/l)-3 ± 3-5 ± 2*-6 ± 2*-4 ± 3*
Mixed venous pH7.34 ± 0.037.26 ± 0.03*7.28 ± 0.04*7.32 ± 0.04
Mixed venous PCO2 (mmHg)43 ± 448 ± 5*43 ± 442 ± 3
Mixed venous PO2 (mmHg)38 ± 423 ± 3*37 ± 439 ± 4
Mixed venous HCO3- (mmol/l)23 ± 321 ± 320 ± 221 ± 2
Mixed venous base excess (mmol/l)-3 ± 3-6 ± 3*-7 ± 2*-5 ± 2*
Mesenteric venous pH7.34 ± 0.037.26 ± 0.03*7.30 ± 0.05*7.32 ± 0.04
Mesenteric venous PCO2 (mmHg)42 ± 549 ± 5*41 ± 441 ± 4
Mesenteric venous PO2 (mmHg)43 ± 726 ± 3*42 ± 643 ± 5
Mesenteric venous HCO3- (mmol/l)23 ± 322 ± 220 ± 2*21 ± 2
Mesenteric venous base excess (mmol/l)-3 ± 3-5 ± 2*-6 ± 2*-5 ± 2*
Arterial lactate (mmol/l)1.6 ± 0.53.7 ± 1.7*3.9 ± 2.0*3.2 ± 1.5*

Values are expressed as mean ± standard deviation. *P < 0.05 versus basal. PCO2, partial carbon dioxide tension; PO2, partial oxygen tension.

Effects on partial carbon dioxide tension gradients

Mixed and mesenteric venoarterial and urinary bladder and ileal ΔPCO2 differences increased during ischaemia. Ileal ΔPCO2 was higher than other PCO2 gradients during ischaemia (Fig. 1). The change in ileal ΔPCO2 (20 ± 10 mmHg) during ischaemia was greater than that in bladder ΔPCO2 (8 ± 7 mmHg) and in Pv–aCO2 (9 ± 5 mmHg) and Pvm–aCO2 (10 ± 3 mmHg; P < 0.05 for bladder ΔPCO2, Pv–aCO2 and Pvm–aCO2 versus ileal ΔPCO2). However, all PCO2 gradients returned to basal values after reperfusion, except for bladder ΔPCO2, which remained elevated (Fig. 1).
Figure 1

Behaviour of PCO2 gradients. Shown are the various partial carbon dioxide tension (PCO2) gradients in basal conditions, during ischaemia and after reperfusion.

Discussion

The main finding in the present study is the consistent expression of hypercapnia during low flow states. High PCO2 values were evident in veins, ileum and even urinary bladder. In contrast to the other carbon dioxide gradients, bladder ΔPCO2 remained elevated after reperfusion. The prevention, detection and correction of tissue dysoxia are main goals in the management of critically ill patients [1]. Gastric tonometry has been considered the only available method to track tissue oxygenation in the clinical arena [1]. However, tissue hypercapnia is not just a marker of dysoxia but is also an indicator of hypoperfusion. Tissue and venous PCO2 remain unchanged in states of tissue dysoxia with preserved blood flow, such as hypoxic and anaemic hypoxia [13-15]. On the other hand, in a high flow state, such as sepsis, measurements of intramucosal acidosis remain helpful because of the frequent presence of microcirculatory derangements [16]. Moreover, increased blood flow may correct tissue hypercapnia in endotoxaemia [17]. Although most studies dealing with tissue capnometry have focused on the gastrointestinal tract, others have been performed in muscle [18,19], renal parenchyma [20,21] and subcutaneous tissue [22]. Few studies have assessed urinary PCO2 for the monitoring of tissue oxygenation. Lin and coworkers [23] measured urinary PCO2 in critically ill patients to evaluate the adequacy of perfusion. Urinary PCO2 was higher in shock than in control patients (79 ± 10 mmHg versus 43 ± 2 mmHg; P < 0.0001). Lang and colleagues [11] measured urinary bladder gases using a fibreoptic sensor in a swine model of ischaemia/reperfusion. After 30 min of aortic clamping bladder PCO2 increased from 57 ± 5 mmHg to 117 ± 7 mmHg, and it returned to baseline after 60 min of reperfusion. Clavijo-Alvarez and coworkers [12] studied this issue in a model of haemorrhagic shock in which pigs were bled and kept at a mean arterial pressure of 40 mmHg until decompensation. Animals were then resuscitated with shed blood plus lactated Ringer's solution and observed for 2 hours. In contrast to our findings, those investigators found greater increases in bladder PCO2; basal PCO2 was 49 ± 6 mmHg and increased to 71 ± 7 mmHg at the end of shock. Jejunal intramucosal PCO2 exhibited similar behaviour. These differences might be related to the use of different animal species but also, and primarily, to the longer period of shock. Because the pigs in the study by Clavijo-Alvarez and coworkers [12] reached a lower cardiac output than did the sheep in our study, changes in surrogates of hypoperfusion such as base excess bicarbonate and bladder PCO2 were more pronounced. Nevertheless, gut intramucosal acidosis was similar in both studies, which might be related to the greater vulnerability of sheep intestinal mucosa to hypoperfusion. In addition, differences might be explained by diverse surgical preparations and methods for measuring intramucosal PCO2. Clavijo-Alvarez and coworkers completely isolated the bladder, and the PCO2 sensor was encased within the mucosa so that they could avoid interference. In this way, the measurements should reflect those from the bladder wall more accurately. Furthermore, they used a more sensitive method to measure PCO2. Nevertheless, it is difficult to reproduce this type of measurement in patients, and our methodology seems more suitable for clinical application. Although tissue and venous hypercapnia is a widespread consequence of hypoperfusion, our experiments reveal that the increase in PCO2 is higher in ileal mucosa than in bladder mucosa and mixed and mesenteric venous blood. The underlying mechanism producing this preferential elevation in ileal ΔPCO2 might be related to particular characteristics of villi microcirculation. Countercurrent circulation might induce a functional shunt that could place distal microvilli segments at ischaemic risk [24]. There is some controversy regarding the meaning of intramucosal PCO2; specifically, does it reflect whole wall or superficial mucosal perfusion? An ileal ΔPCO2 greater than the Pvm-aCO2 suggests that tonometric PCO2 reflects mucosal rather than transmural PCO2. On the other hand, the similar increase in bladder–arterial and systemic and intestinal venoarterial PCO2 gradients suggests the presence of similar degrees of hypoperfusion. As previously described [25], the fraction of cardiac output directed to gut (superior mesenteric artery blood flow/cardiac output) decreased during ischaemia (from 0.23 ± 0.06 to 0.16 ± 0.07; data not shown). However, this was not enough to produce differences between systemic and intestinal venoarterial PCO2 gradients. Another interesting finding of this study lies in the persistence of bladder intramucosal acidosis during reperfusion. Recent studies indicated that ischaemia/reperfusion can cause acute inflammation and contractile dysfunction of the bladder [26]. Bajory and coworkers [27] demonstrated severe microcirculatory derangements such as decreased functional capillary density, red blood cell velocity, venular and arteriolar diameter, and enhanced macromolecular leakage after bladder ischaemia/reperfusion. We speculate that these microcirculatory alterations might lead to decreased carbon dioxide removal. Again, differential susceptibility to injury between species could explain differences from other studies [11,12]. Limitations of the present study could be related to the method of measurement of bladder PCO2. First, tonometric measurement of PCO2 has drawbacks [8]. Second, urine itself could potentially influence tonometric PCO2 beyond perfusion deficits. In fact, urine can have variable carbon dioxide content, resulting, for example, from different grades of carbonic anhydrase inhibition or from systemic bicarbonate administration [28]. Actually, failure to observe an appropriate increase in urinary-blood PCO2 during bicarbonate loading has been employed as an index of reduced distal nephron proton secretion in distal renal tubular acidosis [28]. Changes in systemic oxygenation can also modify urine composition. Moriguchi and coworkers [29] have showed that urinary bicarbonate, calculated from urinary PCO2 and pH, increases after anaerobic exercise. Those authors related these findings to systemic carbon dioxide production and later urinary excretion [29]. They also described a circadian rhythm in urinary bicarbonate elimination [30]. Moreover, an elevated bladder ΔPCO2 could also represent a late manifestation of renal hypoperfusion. Further studies are needed to clarify the influence of renal carbon dioxide excretion on bladder PCO2.

Conclusion

Our data suggest that bladder ΔPCO2 could be a useful indicator of tissue perfusion. However, intestinal ΔPCO2 is the more sensitive carbon dioxide gradient for monitoring low flow states. Further studies are needed to establish the definitive monitoring value of urinary PCO2.

Key messages

• Urinary bladder ΔPCO2 may be a useful indicator of tissue perfusion, but intestinal ΔPCO2 is the more sensitive carbon dioxide gradient for the monitoring of low flow states. • The fact that the observed ileal ΔPCO2 was greater than Pvm-aCO2 suggests that tonometric PCO2 reflects mucosal rather than transmural PCO2.

Abbreviations

CaO2 = arterial oxygen content; CvmO2 = mesenteric venous oxygen content; CvO2 = mixed venous oxygen content; DO2 = oxygen transport; PCO2 = partial carbon dioxide tension; PO2 = partial oxygen tension; Pv–aCO2 = mixed venous-arterial PCO2 difference; Pvm–aCO2 = mesenteric venous–arterial PCO2 difference; Q = cardiac output; VO2 = oxygen consumption.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

AD was responsible for the study concept and design, analysis and interpretation of data, and drafting of the manuscript. MOP, VSKE, GM and HSC performed acquisition of data and contributed to drafting of the manuscript. BM and ML conducted blood determinations and contributed to drafting of the manuscript. MB and GF performed the surgical preparation and contributed to the discussion. EE helped in the drafting of the manuscript and conducted a critical revision for important intellectual content. All authors read and approved the final manuscript.
  30 in total

1.  Increased ileal-mucosal-arterial PCO2 gap is associated with impaired villus microcirculation in endotoxic pigs.

Authors:  I F Tugtekin; P Radermacher; M Theisen; M Matejovic; A Stehr; F Ploner; K Matura; C Ince; M Georgieff; K Träger
Journal:  Intensive Care Med       Date:  2001-04       Impact factor: 17.440

2.  Mesenteric vasoconstriction in cardiogenic shock in pigs.

Authors:  P M Reilly; S MacGowan; M Miyachi; H J Schiller; S Vickers; G B Bulkley
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

3.  Sublingual capnometry versus traditional markers of tissue oxygenation in critically ill patients.

Authors:  Paul E Marik; Aleksandr Bankov
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

4.  Skeletal muscle acidosis correlates with the severity of blood volume loss during shock and resuscitation.

Authors:  C Sims; P Seigne; M Menconi; J Monarca; C Barlow; J Pettit; J C Puyana
Journal:  J Trauma       Date:  2001-12

5.  Effects of hemorrhage on gastrointestinal oxygenation.

Authors:  A Dubin; E Estenssoro; G Murias; H Canales; P Sottile; J Badie; M Barán; F Pálizas; M Laporte; M Rivas Díaz
Journal:  Intensive Care Med       Date:  2001-11-10       Impact factor: 17.440

6.  Venoarterial CO(2) difference during regional ischemic or hypoxic hypoxia.

Authors:  B Vallet; J L Teboul; S Cain; S Curtis
Journal:  J Appl Physiol (1985)       Date:  2000-10

7.  Gastric intramucosal pH. A better predictor of multiorgan dysfunction syndrome and death than oxygen-derived variables in patients with sepsis.

Authors:  P E Marik
Journal:  Chest       Date:  1993-07       Impact factor: 9.410

8.  Circadian changes in urinary bicarbonate, nitric oxide metabolites and pH in female player during handball camp involved in an exercise, rest and sleep cycle.

Authors:  Tetsushi Moriguchi; Teruichi Shimomitsu; Yuko Odagiri; Shiro Ichimura; Jun Fukuda; Akio Tomoda
Journal:  Tohoku J Exp Med       Date:  2002-04       Impact factor: 1.848

9.  The role of endothelin-1 in ischemia-reperfusion induced acute inflammation of the bladder in rats.

Authors:  Zoltán Bajory; Jörg Hutter; Fritz Krombach; Konrad Messmer
Journal:  J Urol       Date:  2002-09       Impact factor: 7.450

10.  Intramucosal-arterial PCO2 gap fails to reflect intestinal dysoxia in hypoxic hypoxia.

Authors:  Arnaldo Dubin; Gastón Murias; Elisa Estenssoro; Héctor Canales; Julio Badie; Mario Pozo; Juan P Sottile; Marcelo Barán; Fernando Pálizas; Mercedes Laporte
Journal:  Crit Care       Date:  2002-08-28       Impact factor: 9.097

View more
  3 in total

1.  Monitoring the conjunctiva for carbon dioxide and oxygen tensions and pH during cardiopulmonary bypass.

Authors:  Irwin K Weiss; Sherwin J Isenberg; David L McArthur; Madeline Del Signore; John S McDonald
Journal:  J Extra Corpor Technol       Date:  2011-03

Review 2.  Regional capnometry to evaluate the adequacy of tissue perfusion.

Authors:  Stéphane Bar; Marc-Olivier Fischer
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

3.  Bladder mucosal CO2 compared with gastric mucosal CO2 as a marker for low perfusion states in septic shock.

Authors:  Gemma Seller-Pérez; Manuel E Herrera-Gutiérrez; Cesar Aragón-González; Maria M Granados; Juan M Dominguez; Rocío Navarrete; Guillermo Quesada-García; Juán Morgaz; Rafael Gómez-Villamandos
Journal:  ScientificWorldJournal       Date:  2012-04-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.